Key indicators: single-crystal X-ray study; T = 273 K; mean (C-C) = 0.007 Å; disorder in solvent or counterion; R factor = 0.074; wR factor = 0.214; data-toparameter ratio = 12.4.
In the title molecular salt, C 17 H 17 N 5 + Á2ClO 4 À , the dihedral angles between the fused-ring system and the pendant fiveand six-membered heterocyclic rings are 6.4 (2) and 41.29 (19) , respectively. The O atoms of both perchlorate anions are disordered over two sets of sites with occupancy ratios of 0.614 (8):0.386 (8) and 0.591 (7):0.409 (7). An intramolecular C-HÁ Á ÁN contact occurs in the cation. In the crystal, the components are linked by N-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds and -stacking interactions [centroid-centroid separation = 3.642 (3) Å ].
Related literature
For background to the biological properties of imidazopyridine compounds, see: Kaminski & Doweyko (1997) ; Sanfillipo et al. (1988) ; Lhassani et al. (1999) . For hydrogen-bond motifs, see: Bernstein et al. (1995) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Data collection: PROCESS-AUTO (Rigaku, 1998); cell refinement: PROCESS-AUTO; data reduction: CrystalStructure (Rigaku/ MSC, 2004); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997); software used to prepare material for publication: WinGX (Farrugia, 1999) and PLATON (Spek, 2009 (Sanfillipo et al., 1988) and antiviral (Lhassani et al., 1999) properties of imidazo[1,2-a]pyridine derivatives have been described.
The title salt comprises a double protonated 2-[2-(1H-imidazol-3-ium-5-yl)ethyl]-3-(pyridin-2-yl)-2H-imidazo [1,5-a]pyridin-4-ium cation and two perchlorate anion (Fig. 1) . The interatomic distances and angles in the title salt show no anomalies.
The molecular structure of the title compound, (I), contains one intramolecular C-H···N contact leading to the formation of a six-membered ring with graph-set descriptor S(6) (Bernstein et al., 1995) . In the crystal structure, intermolecular C-H···O and N-H···O type hydrogen bonds and π-π stacking interactions between the (N2/C2-C6) and (N3/C8-C12) pyridine rings interconnect the ions into a three-dimensional supramolecular structure (Table 1) .
Histamine-HCl (8 mmol, 1.18 g) was dissolved in argon saturated methanol and the solution was placed on a magnetic stirrer at room temperature. 2-Pyridinecarboxaldehyde (10 mmol, 1.08 g) was dissolved in argon saturated methanol and this solution was added to the histamine solution slowly. The final solution was left on a magnetic stirrer and temperature was raised to 333 K and the solution was left there for 24 h. Solvent volume was reduced and the solution was left for crystallization. After several days, brown blocks of (I) were separated, which were collected and dried.
Refinement
H atoms were positioned geometrically and treated using a riding model, fixing the bond lengths at 0.86, 0.93 and 0.97 Å for NH, CH and CH 2 groups, respectively. The displacement parameters of the H atoms were constrained as U iso (H)= 1.2U eq . In the compound, the O atoms of the two perchlorate anions show positional disorder and the refined site-occupancy factors of the disordered parts, viz. (O1A-O4A/O1B-O4B) and (O5A-O8A/O5B-O8B), are 0.614 (8)/0.386 (8)% and 0.591 (7)/0.409 (7)%, respectively. 
Special details
Geometry. 1.307 (6) C16-H16 0.9300 N5-C17
1.366 (6) C17-H17 0.9300 O2B-Cl1-O1B 107.4 (7) C3-C4-H4 119.9 O2B-Cl1-O3B 108.1 (7) C5-C4-H4 119.9 O1B-Cl1-O3B 117.0 (9) C6-C5-C4 121.9 (5) O2A-Cl1-O3A 110.7 (5) C6-C5-H5 119.1
